Pharmacology Flashcards
P450 inducers
Phenytoin
Carbamazepine
Barbiturates (phenobarbitone)
Rifampicin
St John’s Wort
Chronic alcohol intake
Griseofulvin
Smoking
P450 inhibitors
Ciprofloxacin
Erythromycin
Isoniazid
Cimetidine
Omeprazole
Amiodarone
Allopurinol
Ketoconazole, fluconazole
Fluoxetine, sertraline
Ritonavir
Sodium valproate
Acute alcohol intake
Quinupristin
Side effects of rifampicin
- Hepatitis
- Orange secretions
- Flu like symptoms
Side effects of isoniazid
- Peripheral neuropathy
- Hepatitis
- Agranulocytosis
Side effects of pyrazinamide
- Hyperuricaemia causing gout
- Arthralgia
- Myalgia
- Hepatitis
Side effects of ethambutol
- Optic neuritis
Side effects of amoxicllin
Rash with infectious mononucleosis
Side effects of co-amox
Cholestasis
Side effects of flucloxacillin
Cholestasis
Side effects of erythromycin
- GI upset
- Prolonged QT interval
Side effects of ciprofloxacin
- Lower seizure threshold
- Tendonitis
Side effect of metronidazole
- Reaction following alcohol ingestion
Side effect of doxycycline
- Photosensitivity
Side effect of trimethoprim
- Rashes, including photosensitivity
- Pruritis
- Suppression of haematopoiesis
Criteria for liver transplant in paracetamol overdose
- Arterial pH <7.3 24 hours after ingestion
or all of:
- Prothrombin time >100 seconds
- Creatinine >300umol/L
- Grade III or IV encepahlopathy
Monitoring requirements for statins
LFTs at baseline, 3 months and 12 months
Monitoring requirements for ACEi
U&E prior to treatment, after increasing dose, and at least annual
Monitoring requirements for amiodarone
TFT, LFT, U&E and CXR prior to treatment
TFT, LFT every 6 months
Monitoring requirements for methotrexate
FBC, U&E, and LFTs before starting treatment, and repeated weekly until therapy stabilised, thereafter monitored 2-3 monthly
Monitoring requirements for azathioprine
FBC and LFT before treatment
FBC weekly for first 4 weeks
FBC and LFT every 3 months